Iovance Biotherapeutics (IOVA) Notes Payables (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Notes Payables of $1.0 million for Q1 2026, little changed year-over-year from $1.0 million in Q1 2025, and little changed quarter-over-quarter from $1.0 million in Q4 2025.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Notes Payables (2010 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Notes Payables for 9 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables changed 0.0% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (changed 0.0% YoY), while the FY2025 annual figure was $1.0 million, changed N/A from the prior year.
- Notes Payables held at $1.0 million in Q1 2026 per IOVA's latest filing, from $1.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $1.0 million in Q1 2025 and bottomed at $1.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.95 Bn | 3.66 Bn | 55.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2012 | 5.00 Mn |
| Sep 30, 2012 | 7.66 Mn |
| Jun 30, 2012 | 8.74 Mn |
| Mar 31, 2012 | 10.67 Mn |
| Dec 31, 2011 | 7.94 Mn |
| Sep 30, 2011 | 6.29 Mn |
| Jun 30, 2011 | 1.74 Mn |
| Dec 31, 2010 | 792,575.00 |